Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Dec 15;38(12):1445-1450.
doi: 10.7507/1002-1892.202408094.

[Comparative study on effectiveness of injecting platelet-rich plasma with different concentrations of leukocytes under ultrasound in treatment of supraspinatus tendon injury]

[Article in Chinese]
Affiliations
Comparative Study

[Comparative study on effectiveness of injecting platelet-rich plasma with different concentrations of leukocytes under ultrasound in treatment of supraspinatus tendon injury]

[Article in Chinese]
Xu Li et al. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. .

Abstract

Objective: To compare effectiveness of injecting platelet-rich plasma (PRP) with different concentrations of leukocytes under ultrasound in treatment of supraspinatus tendon injury.

Methods: A clinical data of 30 patients with supraspinatus tendon injury, who met the selection criteria and were admitted between December 2022 and December 2023, was retrospectively analyzed. Thirty patients were treated with 4 injections of leukocyte-poor PRP (LP-PRP, n=10), leukocyte-rich PRP (LR-PRP, n=11), and triamcinolone ( n=9), with an interval of 7-10 days between each injection. There was no significant difference between groups ( P>0.05) in the age, gender, disease duration, affected shoulder side, Ellman classification, preoperative visual analogue scale (VAS) score, Constant score, Disabilities of the Arm, Shoulder, and Hand (DASH) score, and American Shoulder and Elbow Surgeons (ASES) score. At 1, 3, and 6 months after injection, the shoulder pain and function were evaluated by using the VAS score, Constant score, DASH score, and ASES score. MRI was conducted to observe supraspinatus tendon healing.

Results: No severe adverse reactions was observed in all groups. All patients were followed up 6-7 months, with an average of 6.5 months. After injection, the ASES score and Constant score gradually increased in the LR-PRP group and LP-PRP group, while the VAS score and DASH score decreased, with significant differences compared to before injection ( P<0.05). Except for no significant difference between 3 and 6 months after injection in LR-PRP group ( P>0.05), the above scores showed significant differences between different time points ( P<0.05). At 1 month after injection, the Constant score in triamcinolone group significantly increased compared to before injection, while the VAS score significantly decreased ( P<0.05). There was no significant difference in all scores between other time points in the triamcinolone group ( P>0.05). Except for 1 month after injection, there was no significant difference in Constant score and VAS score between groups ( P>0.05). At all other time points, the LR-PRP group and LP-PRP group had better scores than the triamcinolone group ( P<0.05). There was no significant difference between the LR-PRP group and the LP-PRP group ( P>0.05). MRI showed that only 4 patients in the LP-PRP group had signs of repair at the supraspinatus tendon injury site at 6 months after injection, while no significant tendon repair sign was observed in the other patients.

Conclusion: Compared with triamcinolone treatment, multiple injections of LP-PRP and LR-PRP under ultrasound can promote the recovery of shoulder joint function and significantly relieve pain in patients with supraspinatus tendon injury, and imaging improvement can be seen after LP-PRP treatment.

目的: 探讨超声引导下多次注射不同白细胞浓度富血小板血浆(platelet-rich plasma,PRP)治疗冈上肌腱损伤的临床疗效。.

方法: 回顾分析2022年12月—2023年12月收治且符合选择标准的30例冈上肌腱损伤患者临床资料,分别注射贫白细胞PRP(leukocyte-poor PRP,LP-PRP)10例、富白细胞PRP(leukocyte-rich PRP,LR-PRP)11例、曲安奈德9例治疗,共注射4次,每2次注射间隔7~10 d。3组患者年龄、性别、病程、患肩侧别、Ellman分型以及术前疼痛视觉模拟评分(VAS)、Constant评分、上肢功能障碍评定量表(DASH)评分、美国肩肘外科评分(ASES)等基线资料比较,差异均无统计学意义( P>0.05)。注射后1、3、6个月,采用VAS评分、Constant评分、DASH评分、ASES评分评价肩关节疼痛及功能;MRI复查观察冈上肌腱愈合情况。.

结果: 3组治疗过程无严重不良反应发生。患者均获随访,随访时间6~7个月,平均6.5个月。LR-PRP组、LP-PRP组注射后ASES评分、Constant评分逐渐增高,VAS评分、DASH评分降低,与注射前差异均有统计学意义( P<0.05);注射后除LR-PRP组3、6个月间差异无统计学意义( P>0.05)外,上述评分其余时间点间差异均有统计学意义( P<0.05)。曲安奈德组注射后1个月Constant评分较注射前增高、VAS评分降低( P<0.05),其余时间点间各项评分差异均无统计学意义( P>0.05)。除注射后1个月3组Constant评分、VAS评分差异无统计学意义( P>0.05)外,其余时间点各项评分LR-PRP组和LP-PRP组均优于曲安奈德组( P<0.05);LR-PRP组和LP-PRP组间差异均无统计学意义( P>0.05)。 MRI复查示仅LP-PRP组4例患者注射后6个月冈上肌腱损伤部位较前有修复痕迹,其余患者均未观察到明显肌腱修复迹象。.

结论: 与曲安奈德治疗相比,超声引导下多次注射LP-PRP及LR-PRP均可促进冈上肌腱损伤患者肩关节功能恢复,有效缓解疼痛,且LP-PRP治疗后可见影像学改善。.

Keywords: Leukocyte-poor platelet-rich plasma; leukocyte-rich platelet-rich plasma; rotator cuff injury; supraspinatus tendon.

PubMed Disclaimer

Conflict of interest statement

利益冲突 在课题研究和文章撰写过程中不存在利益冲突;经费支持没有影响文章观点和对研究数据客观结果的统计分析及其报道

Figures

图 1
图 1
Diagram of Supraspinatus tendon injury site and puncture process under ultrasound 超声显示冈上肌腱损伤部位并穿刺
图 2
图 2
Change trends of the shoulder pain and function scores in 3 groups 3组肩关节疼痛及功能评分变化趋势
图 3
图 3
MRI before injection (left) and at 6 months after injection (right) in 3 groups 3组注射前(左)及注射后6个月(右)MRI

Similar articles

References

    1. 尹正勃, 陈志安, 尹妮, 等 肩袖损伤修复的生物治疗进展及展望. 中国修复重建外科杂志. 2023;37(9):1169–1176. - PMC - PubMed
    1. Zhang Y Clinical effects of sodium hyaluronate combined with platelet-rich plasma injection on rotator cuff injury in arthroscopic repair. Regen Ther. 2023;24:161–166. doi: 10.1016/j.reth.2023.06.010. - DOI - PMC - PubMed
    1. 李旭, 李军, 郭孝菊, 等 肩袖损伤中不同保守治疗策略的应用现状及研究进展. 生物骨科材料与临床研究. 2024;21(4):87–90, 93.
    1. Sheth U, Dwyer T, Smith I, et al Does platelet-rich plasma lead to earlier return to sport when compared with conservative treatment in acute muscle injuries? A systematic review and meta-analysis. Arthroscopy. 2018;34:281–288. doi: 10.1016/j.arthro.2017.06.039. - DOI - PubMed
    1. Le ADK, Enweze L, DeBaun MR, et al Current clinical recommendations for use of platelet-rich plasma. Curr Rev Musculoskelet Med. 2018;11(4):624–634. doi: 10.1007/s12178-018-9527-7. - DOI - PMC - PubMed

LinkOut - more resources